Compound Detail
CHEMBL1027
TIAGABINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1027 |
| Name | TIAGABINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PBJUNZJWGZTSKL-MRXNPFEDSA-N |
| Therapeutic | ✓ Yes |
5
Targets
63
Activities
3
Assay Types
9
PK Parameters
20
Publications
10
Known Names
6
Indications
Molecular Properties
375.6
MW (Da)
5.04
ALogP
4
HBA
1
HBD
40.5
PSA (Ų)
0.77
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1997 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Epilepsy Anxiety Schizophrenia Cocaine-Related Disorders Sleep Apnea, Obstructive Alcoholism
ATC Classification
N03AG06
tiagabine
Level 1: NERVOUS SYSTEM
Level 2: ANTIEPILEPTICS
Activity Summary
IC50 50 meas. best 7.43
Ki 11 meas. best 7.77
Kd 2 meas. best 7.39
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium- and chloride-dependent GABA transporter 1 CHEMBL1903 | Ki | 7.77 | 7.545 | 17.0 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 CHEMBL5445 | Ki | 7.56 | 7.4233 | 27.5 | 9 |
| Sodium- and chloride-dependent GABA transporter 1 CHEMBL5445 | IC50 | 7.43 | 6.8483 | 37.1 | 18 |
| Sodium- and chloride-dependent GABA transporter 1 CHEMBL1903 | Kd | 7.39 | 7.11 | 40.5 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 CHEMBL1903 | IC50 | 7.16 | 6.735 | 70.0 | 4 |
| Sodium- and chloride-dependent GABA transporter 1 CHEMBL4054 | IC50 | 7.16 | 5.8529 | 70.0 | 17 |
| Unchecked CHEMBL612545 | IC50 | 6.8 | 6.8 | 159.0 | 1 |
| GABA transporter 2 CHEMBL4228 | IC50 | 6.75 | 6.595 | 180.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 1.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.6 | mL.min-1.kg-1 | Homo sapiens |
| F | 90.0 | % | Homo sapiens |
| Fu | 0.04 | - | Homo sapiens |
| Fu | 0.04 | - | Homo sapiens |
| MRT | 12.0 | hr | Homo sapiens |
| T1/2 | 10.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15509161 | 10.1021/jm040809c | Sodium- and chloride-dependent GABA transporter 1 | 14 |
| 30376325 | 10.1021/acs.jmedchem.8b01602 | Sodium- and chloride-dependent GABA transporter 1 | 12 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 25698617 | 10.1016/j.bmc.2015.01.035 | Sodium- and chloride-dependent GABA transporter 1 | 4 |
| 23398473 | 10.1021/jm301872x | GABA transporter 2 | 3 |
| 30718063 | 10.1016/j.bmc.2019.01.024 | GABA transporter 4 | 2 |
| 23336362 | 10.1021/jm301800j | Sodium- and chloride-dependent GABA transporter 1 | 2 |
| 20219271 | 10.1016/j.ejmech.2010.02.029 | Unchecked | 2 |
| 29886082 | 10.1016/j.bmc.2018.05.049 | Sodium- and chloride-dependent GABA transporter 1 | 2 |
| 25679268 | 10.1021/jm5015428 | Sodium- and chloride-dependent GABA transporter 1 | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| 30777661 | 10.1016/j.bmc.2019.02.015 | Sodium- and chloride-dependent GABA transporter 1 | 2 |
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| 23859778 | 10.1016/j.bmc.2013.06.038 | Sodium- and chloride-dependent GABA transporter 1 | 2 |
| 29886082 | 10.1016/j.bmc.2018.05.049 | GABA transporter 4 | 2 |
| 30718063 | 10.1016/j.bmc.2019.01.024 | Sodium- and chloride-dependent GABA transporter 1 | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| 31097402 | 10.1016/j.bmc.2019.05.001 | Sodium- and chloride-dependent GABA transporter 1 | 2 |
Data from ChEMBL 36 via Core Engine